KEY FINDINGS The North America pharmaceutical continuous manufacturing market is set to record a CAGR of 9.95% during the forecast period, 2021-2028. The increasing adoption of advanced technologies, the large presence of pharmaceutical & biopharmaceutical companies, and the higher adoption of advanced technologies, drive market growth.
MARKET INSIGHTS The North America pharmaceutical continuous manufacturing market growth analysis entails the assessment of Canada and the United States.The Canadian pharmaceutical industry is transitioning to respond to new realities.
These include the unprecedented expiration of patents for several blockbuster drugs and the cost containment measures from both private and public payers.Such external forces, coupled with the competitive global corporate dynamic for investment and enhanced returns, will aid in reshaping their operations.
The changes at the global level have a deep impact on the Canadian pharmaceutical industry, leading to new opportunities and threats.According to the government, the pharmaceutical industry entails an ecosystem of local and multinational companies.
Further, the Canadian Generic Pharmaceutical Association (CGPA) has ten member companies. Of these, more than half are under non-Canadian corporations. Moreover, branded pharmaceutical MNEs represent the largest portion of the drug sales and R&D investment. Such aspects contribute to the overall growth of the market.
COMPETITIVE INSIGHTS Some of the major players in the market include Hosokawa Micron Corporation, Eli Lilly & Company, Glatt GmbH, Gebruder Lodige Maschinenbau GmbH, Korsch AG, etc.
Our report offerings include: • Explore key findings of the overall market • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges) • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions • Market Segmentation cater to a thorough assessment of key segments with their market estimations • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc. • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc. • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Companies mentioned 1. COPERION GMBH 2. ELI LILLY & COMPANY 3. GEA GROUP AG 4. GEBRUDER LODIGE MASCHINENBAU GMBH 5. GLATT GMBH 6. HOSOKAWA MICRON CORPORATION 7. KORSCH AG 8. LB BOHLE MASCHINEN + VERFAHREN GMBH 9. MUNSON MACHINERY COMPANY 10. PFIZER INC 11. SIEMENS HEALTHINEERS 12. SYNTEGON (FORMERLY BOSCH PACKAGING TECHNOLOGY) 13. THERMO FISHER SCIENTIFIC INC
Our reports have been used by over 10K customers, including:
The global flow imaging microscopy market size is projected to reach USD 45 million by 2025 from USD 32 million in 2020, at a CAGR of 7.4%. The growth of the market is attributed to increasing investment in the field of nanotechnology, growing investments in pharmaceutical R&D, and stringent regulatory guidelines for product quality across...
Global Pharmaceutical Partnering Terms and Agreements 2017 to 2021 report provides a detailed understanding and analysis of how and why companies enter Pharmaceutical partnering deals. This report provides details of the latest Pharmaceutical agreements announced in the life sciences since 2017. The report takes...
120 pages •
By Infiniti Research Limited
• Feb 2021
Global Marine Pharmaceuticals Market 2021-2025 The analyst has been monitoring the marine pharmaceuticals market and it is poised to grow by $ 1.43 bn during 2021-2025 progressing at a CAGR of 8% during the forecast period. Our report on marine pharmaceuticals market provides a holistic analysis, market size and forecast,...
189 pages •
By Global Industry Analysts
• Mar 2021
Project Details:
- StrategyR - A Trademark of Global Industry Analysts, Inc.
- Project Edition: 5
- Influencer Pool: 971
- MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies....
184 pages •
By Global Industry Analysts
• Mar 2021
Project Details:
- StrategyR - A Trademark of Global Industry Analysts, Inc.
- Project Edition: 8
- Influencer Pool: 883
- MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies....
196 pages •
By Global Industry Analysts
• Mar 2021
Project Details:
- StrategyR - A Trademark of Global Industry Analysts, Inc.
- Project Edition: 7
- Influencer Pool: 723
- MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies....
271 pages •
By Global Industry Analysts
• Mar 2021
Project Details:
- StrategyR - A Trademark of Global Industry Analysts, Inc.
- Project Edition: 8
- Influencer Pool: 834
- MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies....
200 pages •
By The Business Research Company
• Mar 2021
Major players in the artificial intelligence (AI) in pharma market are Novartis, IBM Watson, Microsoft Corporation, Merck, GNS Healthcare., Google, AstraZeneca, Atomwise, Inc., Exscientia, and Cyclica. The global AI in pharma market is expected to grow from $0.91 billion in 2020 to $1.27 billion in 2021 at a compound annual growth rate...
The Global Data Historian Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2028. Some of the prominent trends that the market is witnessing include increasing demand for consolidated data for process and performance improvement, growing need for industrial 360...
The Europe medical cyclotron market is expected to reach US$ 59.50 million by 2027 from US$ 47.04 million in 2019, it is estimated to grow at a CAGR of 3.1% from 2020 to 2027. The growth of the market is attributed to key driving factors such as increasing prevalence of cancer and growing inclination toward nuclear scans for accurate diagnosis....
Nuclear Imaging Equipment
Pharmaceutical
Europe
Diagnostic Imaging Density
Health Expenditure
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.